Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected
Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Claudia Monari, Barbara Luciani Pasqua, Filippo Dragoni, Elisabetta Schiaroli, Maurizio Zazzi, Daniela Francisci
Topics & Concepts
NeutralizationTiterNeutralizing antibodyAntibodyVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineCoronavirus disease 2019 (COVID-19)PandemicPotencyImmunologyBiologyDiseaseInfectious disease (medical specialty)In vitroInternal medicineBiochemistrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19